ZYY (08223) released its interim results, with a profit attributable to shareholders of 5.771 million yuan, a decrease of 14.57% compared to the same period last year.
Zi Yuan Yuan (08223) announced its interim results for the six months ending June 30, 2026, with total revenue of RMB 94.416 million, a year-on-year decrease of 53.63%; profit attributable to the company's owners was RMB 5.771 million, a year-on-year decrease of 14.57%; basic earnings per share are 1.24 cents.
ZYY (08223) announced its interim results for the six months ended June 30, 2026, with total revenue at 94.416 million yuan (RMB, same below), a year-on-year decrease of 53.63%; the profit attributable to owners of the company was 5.771 million yuan, a year-on-year decrease of 14.57%; basic earnings per share were 1.24 cents.
Related Articles
MOMENTUM FIN (01152) announced its interim results, with a loss attributable to shareholders of HKD 3.17 million, a year-on-year shift from profit to loss.
CHINA ITS (01900) announced its interim results, with a net profit attributable to shareholders of 27.2 million yuan, a decrease of 92.8% compared to the same period last year.
.png)
Changchun High-Tech Industry (000661.SZ) subsidiary GenSci161 injection clinical trial application approved for acceptance.
MOMENTUM FIN (01152) announced its interim results, with a loss attributable to shareholders of HKD 3.17 million, a year-on-year shift from profit to loss.
CHINA ITS (01900) announced its interim results, with a net profit attributable to shareholders of 27.2 million yuan, a decrease of 92.8% compared to the same period last year.
Changchun High-Tech Industry (000661.SZ) subsidiary GenSci161 injection clinical trial application approved for acceptance.
RECOMMEND
